Marksans Pharma Limited has informed the Exchange regarding a press release dated August 22, 2023, titled "Receipt of USFDA approval for Guaifenesin Extended-Release Tablets (OTC)".
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 22, 2023, titled "Receipt of USFDA approval for Guaifenesin Extended-Release Tablets (OTC)".